Document is current
Any future updates will be listed below
-
Authors
Hirata, Yuki https://orcid.org/0000-0002-0283-6392
Noorani, Ayesha
Song, Shumei https://orcid.org/0000-0002-8128-6287
Wang, Linghua
Ajani, Jaffer A. https://orcid.org/0000-0001-9946-0629
- License Information
-
More Information
Article History
Accepted: 14 April 2023
First Online: 1 June 2023
Competing interests
: J.A.A. has acted as an adviser to Aadi, Arcus, Amgen, Astellas, AZ, BMS, BeiGene, Daiichi, Gilead, Grail, Merck, Novartis, Servier and Zymeworks, and has received institutional research funding from Astellas, BMS, Daiichi, Delta Fly, Gilead, LaNova, Leap, Merck, Prolinx, Taiho, Turning Point and Zymeworks. The other authors declare no competing interests.
